Is Clean Science overvalued or undervalued?

As of September 17, 2021, Clean Science is considered overvalued with a PE ratio of 60.69, significantly higher than its peers, and despite a 12.71% return over the past year, it is trading at a premium compared to its earnings and growth potential.

As of 17 September 2021, the valuation grade for Clean Science has moved from does not qualify to very expensive, indicating a significant shift in its perceived value. The company is currently considered overvalued. Key ratios include a PE ratio of 60.69, an EV to EBITDA of 40.46, and a PEG ratio of 7.28, all of which suggest that the stock is trading at a premium compared to its earnings and growth potential.<BR><BR>In comparison to its peers, Clean Science's PE ratio is notably higher than Godrej Industries Ltd., which has a PE of 46.63 and is rated as attractive, and Deepak Nitrite Ltd., with a PE of 37.97 and also rated very expensive. This disparity highlights Clean Science's overvaluation relative to its industry peers. Additionally, while Clean Science has shown a 12.71% return over the past year, this is less impressive compared to the Sensex's 7.55% return, reinforcing the notion that the stock may not be justifiably priced at its current levels.

When is the next results date for Clean Science?

No Upcoming Board Meetings

Has Clean Science declared dividend?

Clean Science & Technology Ltd has declared a 200% dividend, amounting to ₹2 per share, with an ex-date of February 7, 2025. While recent returns have been positive, longer-term performance shows challenges, particularly a -14.15% total return over the last three years.

Clean Science & Technology Ltd has declared a 200% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 200%<BR>- Amount per share: 2<BR>- Ex-date: 07 Feb 2025<BR><BR>Dividend Yield: 0.13%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the company achieved a price return of 16.09%, a dividend return of 0.15%, resulting in a total return of 16.24%.<BR><BR>Over the past year, the price return was 15.19%, with a dividend return of 0.15%, leading to a total return of 15.34%.<BR><BR>In the 2-year period, the price return stood at 6.7%, while the dividend return was 0.51%, culminating in a total return of 7.21%.<BR><BR>For the 3-year period, the company experienced a price return of -14.99% and a dividend return of 0.84%, resulting in a total return of -14.15%.<BR><BR>In the 4-year period, there was no price return and no dividend return, leading to a total return of 0.0%.<BR><BR>Over the last 5 years, the price return was also 0% with no dividend return, resulting in a total return of 0.0%.<BR><BR>Overall, Clean Science & Technology Ltd has declared a significant dividend, which contributes positively to its returns, particularly in the shorter time frames. However, the longer-term performance indicates some challenges, especially in the 3-year period, where total returns were negative.

Who are the peers of the Clean Science?

Clean Science's peers include Pidilite Inds., SRF, Gujarat Fluoroch, Deepak Nitrite, Himadri Special, Fine Organic, Jubilant Ingrev., Anupam Rasayan, and Alkyl Amines. In terms of returns, Jubilant Ingrev. leads with 44.45% over one year, while Clean Science has a return of 14.36%.

Peers: The peers of Clean Science are Pidilite Inds., SRF, Gujarat Fluoroch, Deepak Nitrite, Himadri Special, Fine Organic, Jubilant Ingrev., Anupam Rasayan, and Alkyl Amines.<BR><BR>Quality Snapshot: Excellent management risk is observed at Clean Science, Deepak Nitrite, Fine Organic, and Alkyl Amines, while Good management risk is found at Pidilite Inds., SRF, and Jubilant Ingrev. Average management risk is noted at Gujarat Fluoroch, Himadri Special, and Anupam Rasayan. In terms of Growth, Excellent growth is seen at Himadri Special, while Average growth is found at Pidilite Inds., SRF, and Anupam Rasayan. Below Average growth is noted at Clean Science, Deepak Nitrite, Fine Organic, Jubilant Ingrev., Gujarat Fluoroch, and Alkyl Amines. For Capital Structure, Excellent capital structure is observed at Clean Science, Pidilite Inds., SRF, Deepak Nitrite, Fine Organic, and Alkyl Amines, while Good capital structure is found at Himadri Special and Gujarat Fluoroch, and Average capital structure is noted at Anupam Rasayan.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Jubilant Ingrev. at 44.45%, while the lowest is Deepak Nitrite at -9.57%. Clean Science's 1-year return is 14.36%, which is higher than Deepak Nitrite but lower than Jubilant Ingrev. Additionally, the peers with negative six-month returns are Deepak Nitrite, Gujarat Fluoroch, and Aether Industri.

Who are in the management team of Clean Science?

As of March 2023, the management team of Clean Science includes Pradeep R Rathi (Chairman), Ashok Ramnarayan Boob (Managing Director), Krishnakumar Ramnarayan Boob (Whole-time Director), and several independent directors, along with a Company Secretary.

As of March 2023, the management team of Clean Science includes the following individuals:<BR><BR>1. Pradeep R Rathi - Chairman & Non Executive Director<BR>2. Ashok Ramnarayan Boob - Managing Director<BR>3. Krishnakumar Ramnarayan Boob - Whole-time Director<BR>4. Sanjay Kothari - Director<BR>5. Ganapati D Yadav - Independent Director<BR>6. Keval Navinchandra Doshi - Independent Director<BR>7. Madhu Dubhashi - Independent Director<BR>8. Mahesh Arvind Kulkarni - Company Secretary & Compliance Officer<BR>9. Siddhartha Ashok Sikchi - Whole-time Director<BR><BR>As of March 2023, the management team of Clean Science comprises a diverse group of leaders with various roles, including executive and independent directors.

What does Clean Science do?

Clean Science and Technology Ltd is a mid-cap company in the specialty chemicals industry, reporting net sales of ₹2,637 Cr and a net profit of ₹741 Cr for Q1 2025. Key metrics include a P/E ratio of 59.00 and a market cap of ₹15,326 Cr.

Overview:<BR>Clean Science and Technology Ltd operates in the specialty chemicals industry and is categorized as a mid-cap company.<BR><BR>History:<BR>The company was originally incorporated as 'Sri Distikemi Private Limited' in 2003 and later changed its name to 'Clean Science and Technology Private Limited' in 2006. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 2,637 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 741 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: INR 15,326 Cr (Mid Cap)<BR><BR>Key Metrics:<BR>P/E: 59.00 <BR>Industry P/E: 47 <BR>Dividend Yield: 0.14% <BR>Debt-Equity: -0.26 <BR>Return on Equity: 18.67% <BR>Price to Book: 10.78 <BR><BR>Contact Details:<BR>Details: No Company Details Available <BR>Registrar Address: Not available.

Who are the top shareholders of the Clean Science?

The top shareholders of Clean Science include promoter Ashok Ramnarayan Boob with 12.8%, 16 mutual fund schemes holding 4.48%, 92 foreign institutional investors with 6.07%, and the highest public shareholder, Anantroop Financial Advisory Services Private Limited, at 3.92%. Individual investors collectively own 7.78% of the shares.

The top shareholders of Clean Science include the promoters, who hold the majority of the shares. The promoter with the highest holding is Ashok Ramnarayan Boob, owning 12.8% of the company. Additionally, there are 16 mutual fund schemes that collectively hold 4.48%, and 92 foreign institutional investors (FIIs) with a combined holding of 6.07%. The highest public shareholder is Anantroop Financial Advisory Services Private Limited, which holds 3.92%. Individual investors also have a notable stake, accounting for 7.78% of the shares.

How big is Clean Science?

As of 24th July, Clean Science & Technology Ltd has a market capitalization of 13,995.00 Cr, with recent Net Sales of 985.50 Cr and a Net Profit of 268.54 Cr. Shareholder's Funds are valued at 1,203.16 Cr, and Total Assets amount to 1,396.28 Cr.

As of 24th July, Clean Science & Technology Ltd has a market capitalization of 13,995.00 Cr, categorizing it as a Mid Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 985.50 Cr and a Net Profit of 268.54 Cr.<BR><BR>For the latest annual period ending in March 2024, the Shareholder's Funds were valued at 1,203.16 Cr, while the Total Assets amounted to 1,396.28 Cr.

Is Clean Science technically bullish or bearish?

As of August 25, 2025, the technical trend has shifted to a moderately strong bearish stance, indicated by bearish signals from MACD, moving averages, Bollinger Bands, KST, and OBV, along with significant underperformance compared to the Sensex.

As of 25 August 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. Key indicators driving this include a bearish MACD on the weekly chart, a bearish moving average on the daily timeframe, and a bearish reading from Bollinger Bands on the monthly chart. Additionally, the KST and OBV both indicate bearish conditions on the monthly timeframe. The stock has underperformed significantly compared to the Sensex over multiple periods, further supporting the bearish outlook.

How has been the historical performance of Clean Science?

Clean Science has shown consistent growth in net sales and profitability, with net sales increasing from 419.30 Cr in March 2020 to 966.64 Cr in March 2025, despite a dip in March 2023. The company also demonstrated strong earnings growth, with profit before tax reaching 356.73 Cr and earnings per share rising to 24.87 in March 2025.

Answer:<BR>The historical performance of Clean Science shows a consistent growth trajectory in net sales and profitability over the years.<BR><BR>Breakdown:<BR>Clean Science has demonstrated significant growth in net sales, increasing from 419.30 Cr in March 2020 to 966.64 Cr in March 2025, with a notable dip in March 2023 at 935.80 Cr. The total operating income followed a similar trend, reaching 966.64 Cr in March 2025. The raw material costs have also risen, from 127.98 Cr in March 2020 to 368.34 Cr in March 2025, while total expenditure (excluding depreciation) increased from 234.02 Cr to 579.02 Cr over the same period. Operating profit (PBDIT) peaked at 512.33 Cr in March 2023 but fell to 426.21 Cr in March 2025. Profit before tax showed a steady increase, reaching 356.73 Cr in March 2025, while profit after tax was 264.41 Cr. The earnings per share (EPS) rose from 13.12 in March 2020 to 24.87 in March 2025, despite a peak of 35.37 in March 2023. The company's total assets grew significantly from 429.88 Cr in March 2020 to 1,599.51 Cr in March 2025, with total liabilities also increasing from 429.88 Cr to 1,599.51 Cr. Cash flow from operating activities improved to 213.00 Cr in March 2025, while the net cash inflow was 9.00 Cr, indicating a positive cash position. Overall, Clean Science has shown robust growth in both revenue and profitability, alongside a solid asset base.

Are Clean Science latest results good or bad?

Clean Science's latest results are concerning, with a 20.88% decline in net profit and a drop in operating margins to 35.61%, despite modest revenue growth. The stock has also fallen 36.44% over the past year, reflecting investor worries about the company's financial health.

The latest results for Clean Science indicate a challenging performance. In the quarter ended September 2025, the company reported a net profit of ₹55.43 crore, which represents a significant decline of 20.88% quarter-on-quarter and 5.65% year-on-year. This drop in profit is concerning, especially when coupled with only a modest revenue growth of 0.71% quarter-on-quarter and 2.72% year-on-year, totaling ₹244.60 crore.<BR><BR>Operating margins have also taken a hit, falling to 35.61%, which is a multi-quarter low and down 550 basis points from the previous quarter. This margin compression suggests that the company is facing increasing operational challenges, including pricing pressures and stagnant volume growth.<BR><BR>Overall, while there was a slight increase in revenue, the sharp decline in net profit and operating margins paints a negative picture of the company's current financial health. The stock has reacted accordingly, showing a decline of 36.44% over the past year, indicating that investors are concerned about the company's ability to maintain its historical performance amidst these challenges.

Should I buy, sell or hold Clean Science?

Which are the latest news on Clean Science?

Why is Clean Science falling/rising?

As of 04-Dec, Clean Science & Technology Ltd's stock is at Rs 891.10, down 0.46%, and has significantly underperformed with a 37.47% year-to-date decline. The stock is nearing its 52-week low and shows bearish trends, compounded by waning investor interest and negative financial results.

As of 04-Dec, Clean Science & Technology Ltd's stock price is falling, currently at Rs 891.10, which reflects a decrease of Rs 4.1 or 0.46%. The stock has been underperforming significantly, with a decline of 3.00% over the past week and a substantial drop of 9.54% over the past month. Year-to-date, the stock has plummeted by 37.47%, while the benchmark Sensex has gained 9.12% during the same period.<BR><BR>Today's performance indicates that the stock is close to its 52-week low, being only 0.71% away from Rs 884.75. It has also been on a downward trend, having fallen for three consecutive days, resulting in a total decline of 2.62% in that timeframe. Furthermore, Clean Science is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which typically signals a bearish trend.<BR><BR>Investor participation appears to be waning, as evidenced by a 6.26% decrease in delivery volume compared to the 5-day average. This lack of interest may contribute to the stock's declining price. Additionally, the company's financial performance has raised concerns, with negative results reported for the quarter ending September 25, including a 14.9% drop in profit before tax and a 17.4% decline in profit after tax compared to previous quarters.<BR><BR>The stock's valuation is considered expensive, with a Price to Book Value ratio of 6.3, and it has consistently underperformed against the benchmark over the last three years. Promoter confidence is also diminishing, as they have reduced their stake in the company by 24% in the previous quarter, which may signal a lack of faith in the company's future prospects. Overall, these factors contribute to the stock's ongoing decline.